Pergamum is a clinical-stage biopharmaceutical company developing state-of-the-art products, based on therapeutic peptides, for local or topical treatment of infections and wounds.
Pergamum was formed by merging and integrating PharmaSurgics AB, DermaGen AB, and Lipopeptide AB into one operational company.